(105 days)
Not Found
No
The summary describes a standard patient monitor with continuous physiological parameter monitoring, storage, display, analysis, and alarming. There is no mention of AI, ML, or any advanced analytical techniques beyond basic parameter analysis and alarming based on set limits. The performance studies listed are standard device verification and validation tests, not AI/ML model performance evaluations.
No.
The document states that the device 'monitors parameters' and 'will indicate alarms in case of abnormity', which are functions of a diagnostic device, not a therapeutic one. It does not mention any treatment or intervention capabilities.
Yes
This device monitors physiological parameters (ECG, Respiration, SpO2, NIBP, IBP, Temp, CO2) and indicates alarms for abnormal values, which provides information for diagnosis. The "Intended Use" also states it indicates "physiologic parameters that have exceeded the limits set by the operator," which suggests it provides data that can be interpreted for diagnostic purposes.
No
The device description explicitly mentions physical dimensions, screen sizes, and includes "Hardware Testing" in the performance studies, indicating it is a physical hardware device with integrated software.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The intended use and device description clearly state that this monitor measures physiological parameters directly from the patient (ECG, Respiration, SpO2, Blood Pressure, Temperature, CO2). It does not analyze samples like blood, urine, or tissue in a laboratory setting.
- The device monitors vital signs. The parameters listed are all vital signs that are measured non-invasively or minimally invasively on the patient's body.
Therefore, this device falls under the category of a patient monitor, which is a different type of medical device than an IVD.
N/A
Intended Use / Indications for Use
The monitor monitors parameters such as ECG (3-lead or 5-lead selectable), Respiration (RESP), Functional arterial oxygen saturation (SpO2), Invasive or noninvasive blood pressure (dual-IBP, NIBP), Temperature (dual-TEMP), Expired C02.
The monitor is intended to be used only under regular supervision of clinical personnel. It is applicable to adult, pediatric, and neonatal usage in a hospital environment and during patient transport inside a healthcare facility. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
Product codes (comma separated list FDA assigned to the subject device)
MHX, DRT, DXN, DSK, FLL, DQA, CCK, DSA, DSI
Device Description
The Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro can perform long-time continuous monitoring of multiple physiological parameters. Also, it is capable of storing, displaying, analyzing and controlling measurements, and it will indicate alarms in case of abnormity so that doctors and nurses can deal with them in time. The patient monitor supports software upgrade online and networking and build-in battery power is available for all the models.
The Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro can monitor physiological parameters including SpO2, NIBP, ECG, RESP, TEMP, C02, IBP. The above is the maximum configuration; the user may select different monitoring parameters in according with specific requirements. The main difference between Patient Monitor models is the screen size as it is illustrated in the table below:
| Product models | Size (LxWxH) | Screen size | Monitoring features |
|---|---|---|---|
| PM-2000A | 10.1-Inch | ||
| PM-2000A+ | 320mmx150mmx265mm | 10.4-Inch | ECG/RESP.SPO2, NIBP, TEMP, IBP, CO2 |
| PM-2000A Pro | 12.1-Inch |
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult, pediatric, and neonatal
Intended User / Care Setting
clinical personnel, hospital environment and during patient transport inside a healthcare facility.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification and Validation testing was done on the Patient Monitor. This premarket notification submission demonstrates that the Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro is substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro
510(k) Summary of Safety and Effectiveness
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92.
The assigned 510(k) number is: K123048
JAN 1 1 2013
Submitter
Advanced Instrumentations, Inc. 6800 N.W. 77th Court Miami, Fl 33166 Telephone: 305-477-6331 Fax: 305-477-5351
Registration # 1066270
Official correspondent :
Jorge Millan, PhD Email: jmillan@hiatec.org 601 West 20 St Hialeah, FL 33010 Phone : (305) 925-1260
Date Prepared:
December 19, 2012
Device name and classification:
- Device Name: Patient Monitor Models PM-2000A, PM-2000A+ & PM-. 2000A Pro
- Regulatory Class: Class II ●
- Device Common Name: Patient Physiological Monitor (with arrhythmia . detection or alarms)
1
K123048 2/4
Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro
Classification:
| Description | Classification | Product
code |
|--------------------------------------------------------------------------------------------|----------------|-----------------|
| 21 CFR 870.1025 Arrhythmia detector and alarm (Including ST-segment measurement and alarm) | II | MHX |
| 21 CFR 870.2300 Cardiac monitor (including cardiotachoment and rate | II | DRT |
| 21 CFR 870.1130 Non-Invasive blood pressure measurement System | II | DXN |
| 21 CFR 870.1110 Blood pressure computer | II | DSK |
| 21 CFR 880.2910 Clinical Electronic Thermometers-Temperature Monitor with | II | FLL |
| 21 CFR 870.2700 Oximeter, Pulse | II | DQA |
| 21 CFR 870.1400 Carbon Dioxide Gas Analyzer | II | CCK |
| 21 CFR 868.2900 cable, transducer and electrode, patient, (including | II | DSA |
| 21 CFR 870.1025 Detector and Alarm, Arrhythmia | II | DSI |
Requlatory Class: Class II
Predicate Device:
iM8, iM8A & iM8B Patient Monitor K113653 Manufacturer: EDAN Instruments
Device Description:
The Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro can perform long-time continuous monitoring of multiple physiological parameters. Also, it is capable of storing, displaying, analyzing and controlling measurements, and it will indicate alarms in case of abnormity so that doctors and nurses can deal with them in time. The patient monitor supports software upgrade online and networking and build-in battery power is available for all the models.
The Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro can monitor physiological parameters including SpO2, NIBP, ECG, RESP, TEMP, C02, IBP. The above is the maximum configuration; the user may select different monitoring parameters in according with specific requirements. The main difference between Patient Monitor models is the screen size as it is illustrated in the table below:
2
3 / 4
Patient Monitor Models PM-2000A. PM-2000A+ & PM-2000A Pro
| Product models | Size (LxWxH) | Screen size | Monitoring features |
|---|---|---|---|
| PM-2000A | 10.1-Inch | ||
| PM-2000A+ | 320mmx150mmx265mm | 10.4-Inch | ECG/RESP.SPO2, NIBP, |
| TEMP, IBP, CO2 | |||
| PM-2000A Pro | 12.1-Inch |
Intended Use:
Device Name: Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro
The device monitors parameters such as ECG (3-lead or 5-lead selectable). Respiration (RESP), Functional arterial oxygen saturation (SpO2), Invasive or noninvasive blood pressure (dual-IBP, NIBP), Temperature (dual-TEMP), and Expired C02.
The monitor is intended to be used only under reqular supervision of clinical personnel. It is applicable to adult, pediatric, and neonatal usage in a hospital environment and during patient transport inside a healthcare facility. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
Contraindications:
It is not intended for use in a patient's home or residence, or when it has not been ordered by a physician.
Non Clinical Tests:
The following quality assurance and product safety measures were applied to the development of the Patient Monitor:
- Software Testing .
- Hardware Testing .
- Biocompatibility data for accessories .
- Electrical Testing .
- . Safety Testing
- Environment Test .
- Risk Analysis ●
- Final Validation .
3
Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro
Comparison to the predicate device:
The subject device has similar technology characteristics and has the same intended use as the predicate device cleared under K113653. Both models use the same technology and manufacturing processes.
Substantially Equivalent Determination:
Verification and Validation testing was done on the Patient Monitor. This premarket notification submission demonstrates that the Patient Monitor Models PM-2000A, PM-2000A+ & PM-2000A Pro is substantially equivalent to the predicate device.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure or a caduceus, rendered in black.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
JAN 1 1 2013
Advanced Instrumentation, Inc. c/o Dr. Jorge Millan 601 West 20th Street Hialeah. FL 33010
Re: K123048
Trade/Device Name: Patient monitor models pm-2000a, pm-2000a+, pm-2000a pro Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia detector and alarm Regulatory Class: Class II Product Code: MHX, DXN, DRT, DSK, FLL, DQA, DSA, DSI Dated: September 28, 2012 Received: October 17, 2012
Dear Dr. Millan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Dr. Jorge Millan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours,
Owen P. Faris -S
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health ·
Enclosure
6
Indications for Use
510(k) Number (if known):
Device Name:
Patient Monitor Models : PM-2000A, PM-2000A+ & PM-2000A Pro
Indications for Use:
The monitor monitors parameters such as ECG (3-lead or 5-lead selectable), Respiration (RESP), Functional arterial oxygen saturation (SpO2), Invasive or noninvasive blood pressure (dual-IBP, NIBP), Temperature (dual-TEMP), Expired C02.
The monitor is intended to be used only under regular supervision of clinical personnel. It is applicable to adult, pediatric, and neonatal usage in a hospital environment and during patient transport inside a healthcare facility. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
Prescription Use X (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
AND/OR
| Concurrence of CDRH, Office of Device Evaluation (ODE) |
|---|
| (Division Sign-Off) |
(Division Sign-Off)
Division of Cardiovascular Devices
Page 1 of __ 1_
510(k) Number